New York City-based Cohero Health, which develops connected health tools and technologies for chronic respiratory diseases, has closed on $10.5 million in Series A funding. This builds on the company’s earlier $9 million Series A round from late 2016, and the extra funding comes from new strategic investors Samsung Next and Omron Healthcare. With seed funding, this brings Cohero's total funding...
A telehealth initiative at Charleston Area Medical Center led to reduced readmission rates for several chronic conditions, the health system reported today.
What led to the reductions wasn’t the advent of video consultations with specialists or sophisticated biometric sensor monitoring, but health information for patients and workflow integration for hospital staff via SmarTigr, TeleHealth...
Ochsner Health System in New Orleans has catapulted itself into the front lines of hospital innovation in the last few years as an early Apple HealthKit adopter, with its in-house "O Bar" app store, and with an initially successful blood pressure monitoring trial, the details of which Chief Clinical Transformation Officer Richard Milani shared at MobiHealthNews' event in June.
At the DPharm...
Qualcomm Life and Boehringer Ingelheim have announced that they will work together to develop the next generation of Boehringer's Respimat connected inhaler. Propeller Health, which developed the original connected inhaler for Boehringer, will continue to work with Boehringer to at least market the existing version of the device.
"The overall goal for Boehringer Ingelheim is to create health...
Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary disease (COPD).
The proposed yearlong trial – which is still not yet recruiting participants – will be an intervention study involving an estimated 380 people with COPD divided into two groups. Both...
Adherium, a Melbourne, Australia-based connected inhaler company, has raised $5.9 million ($8 million Australian) through a private placement of shares with Fidelity. Adherium is publicly traded in Australia. Under the deal, Fidelity will purchase 16 million shares at $0.50 Australian per share, bringing the global asset manager's share in the company to 10 percent.
“Fidelity International are...
Marina Del Rey, California-based Moving Analytics has raised $1.1 million in a round led by Launchpad Digital Health, an accelerator where the startup is currently enrolled, with additional contributions from HealthX Ventures. Moving Analytics makes an app and web portal for post-discharge patient follow-up and rehabilitation.
“A total of 2.5 million patients in the US don’t receive adequate...
There is little evidence that telemedicine interventions consistently improve the quality of life of COPD patients, according to a new systematic review published recently in the International Journal of Chronic Obstructive Pulmonary Disease. Researchers looked at 47 studies of telemedicine use in COPD since 2000 and analyzed 18 that met their inclusion criteria. Of those, just three showed a...
Australia-based ResApp, a public company, has raised $9.74 million ($12.5 million Australian dollars) for its product, a smartphone-based system for diagnosing respiratory conditions. The company sold 62.5 million new ordinary shares at $0.16 ($0.20 AU) per share.
ResApp’s offering essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But instead of...
A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89 percent in a recent clinical study of 524 pediatric patients conducted by the company at Joondalup Health Campus (JHC) and Princess Margaret Hospital (PMH) in Perth, Western Australia.
Perth-based ResApp essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But...
